miR-26a exerts broad-spectrum antiviral effects via the enhancement of RIG-I-mediated type I interferon response by targeting USP15
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.03124-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Jikai Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Xuzhou Medical University , Xuzhou, China. Hauptthemen laut MEDLINE: Interferon Type I, MicroRNAs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation), | Natural Science Research of Jiangsu Higher Education Institutions of China (Natural Science Foundation of Colleges and Universities in Jiangsu Province).
Abstract (Originalsprache)
Host innate immunity is an important defense line against virus infection and is precisely regulated by various factors. Studying the mechanism of virus-host interaction is essential to developing novel antivirals. Being one of the key host natural antiviral responses, host small non-coding RNAs (miRNAs) possess promising antiviral potential worthy of study. Herein, we found that miR-26a exerted broad-spectrum antiviral effect against multiple viruses, e.g., Hepatitis E virus, Vesicular Stomatitis Virus, and Sendai Virus. Mechanistically, miR-26a specifically targets 3′UTR of mRNA to inhibit USP15 expression. USP15 interacted directly with RIG-I to deubiquitinate K63-linked RIG-I, thus negatively regulating type I interferon (IFN) signaling. Consequently, miR-26a, by downregulating USP15, promotes K63 ubiquitination of RIG-I to enhance type I IFN responses, resulting in an active antiviral state against virus infection. Intriguingly, the activation of type I IFN responses could suppress miR-26a expression, serving as an intrinsic negative feedback loop to avoid dysregulated signal activation. Hence, the broad-spectrum antiviral effects of miR-26a and its mode-of-action enriched the interaction networks between miRNAs and innate immunity, providing insights for the development of broad-spectrum antivirals against viral infection. IMPORTANCE miR-26a serves as a potent positive regulator of type I interferon (IFN) responses. By inhibiting USP15 expression, miR-26a promotes RIG-I K63-ubiquitination to enhance type I IFN responses, resulting in an active antiviral state against viruses. Being an intricate regulatory network, the activation of type I IFN responses could in turn suppress miR-26a expression to avoid the disordered activation that might result in the so-called “type I interferonopathy.” The knowledge gained would be essential for the development of novel antiviral strategies against viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathogen Biology and Immunology, Jiangsu Key Laboratory of Immunity and Metabolism, Xuzhou Medical University , Xuzhou, China.
- Jiangsu International Laboratory of Immunity and Metabolism, Xuzhou Medical University , Xuzhou, China.
ORCID-Profile: Jikai Zhang, Renxian Tang, Hongbo Guo, Wenshi Wang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)
- | Natural Science Research of Jiangsu Higher Education Institutions of China (Natural Science Foundation of Colleges and Universities in Jiangsu Province)
- Staring grants for young scientist of Xuzhou Medical University
- 江苏省教育厅 | Natural Science Research of Jiangsu Higher Education Institutions of China
Zitieren
APA
Zhang, J., Li, C., Hou, Y., Liu, D., Li, Q., Wang, Z., Tang, R., Zheng, K., Guo, H., & Wang, W. (2024). miR-26a exerts broad-spectrum antiviral effects via the enhancement of RIG-I-mediated type I interferon response by targeting USP15. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03124-23
Vancouver
Zhang J, Li C, Hou Y, Liu D, Li Q, Wang Z, et al. miR-26a exerts broad-spectrum antiviral effects via the enhancement of RIG-I-mediated type I interferon response by targeting USP15. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03124-23
BibTeX
@article{Zhang2024,
author = {Zhang, Jikai and Li, Chunyang and Hou, Yao and Liu, Dan and Li, Qiudi and Wang, Zijie and Tang, Renxian and Zheng, Kuiyang and Guo, Hongbo and Wang, Wenshi},
title = {miR-26a exerts broad-spectrum antiviral effects via the enhancement of RIG-I-mediated type I interferon response by targeting USP15},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.03124-23}
}
EUVIMED